Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 906-911

  Kawa, Shigeyuki ^a   Nikaido, Toshio ^a   Aoki, Yuji ^a   Zhai, Yali ^a   Kumagaya, Toshiko ^a   Furihata, Kenichi ^a   Fujii, Shingo ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; ISOTRETINOIN; MOFAROTENE; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PANCREAS CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOTRETINOIN; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RETINOIDS; TIME FACTORS; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0030763111     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<906::AID-IJC31>3.0.CO;2-3     Document Type: Article

References (24)

1. BOLD, R.J., ISHIZUKA, J., TOWNSEND, C.M., JR. and THOMPSON, J.C., All-trans retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas, 12, 189-195 (1996).
2. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.I., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature (Genet.), 8, 27-32 (1994).
3. CARMICHAEL, J., DE GRAFF, W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987a).
4. CARMICHAEL, J., DE GRAFF, W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res., 47, 943-946 (1987b).
5. CHELLAPA, S.P., HIEBERT, S., MUDRYJ, M., HOROWITZ, J.M. and NEVINS, J.R., The E2F transcription factor is a cellular target for the Rb protein. Cell, 65, 1053-1061 (1991).
6. CRETTAZ, M., BARON, A., SIEGENTHALER, G. and HUNZIKER, W., Ligand specificities of recombinant retinoic acid receptors RAR-alpha and RAR-beta. Biochem. J., 272, 391-397 (1990).
7. ELIASON, J.F., TEELMANN, K. and CRETTAZ, M., New retinoids and future of retinoids in skin cancer. In: R. Marks (eds), Retinoids in cutaneous malignancy, pp. 157-170, Blackwell, Oxford (1990).
8. HUANG, M.E., YE, Y.C., CHEN, S., CHAI, J.R., LU, J.X., ZHOA, L., GU, L.J. and WANG, Z.Y., Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572 (1988).
9. JIANG, H., LIN, J., SU, Z.Z., COLLART, F.R., HUBERMAN, E. and FISHER, P.B., Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9, 3397-3406 (1994).
10. 3 on the proliferation of pancreatic cancer cell lines. Gastroenterology, 110, 1605-1613 (1996).
11. LIPPMAN, S.M., KAVANAGH, J.J., PAREDES-ESPINOZA, M., DELGADILLO-MADRUENO, F., PAREDES-CASILLAS, P., HONG, W.K., HOLDENER, E. and KRAKOFF, I.H., 13-cis-Retinoic acid plus interferon alpha-2a - highly active systemic therapy for squamous cell carcinoma of the cervix. J. nat. Cancer Inst., 84, 241-245 (1992a).
12. LIPPMAN, S.M., PARKINSON, D.R., ITRI, L.M., WEBER, R.S., SCHANTZ, S.P., OTA, D.M., SCHUSTERMAN, M.A., KRAKOFF, I.H., GUTTERMAN, J.U. and HONG, W.K., 13-cis-Retinoic acid and interferon alpha-2a - effective combination therapy for advanced squamous cell carcinoma of the skin. J. nat. Cancer Inst., 84, 235-241 (1992b).
13. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Develop., 10, 142-153 (1996).
14. LOUVET, C., DJELLOUL, S., FORGUE-LAFITTE, M.E., MESTER, J., ZIMBER, A. and GESPACH, C., Antiproliferative effects of the arotinoid RO 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combination with 5-fluorouracil and interferon-α. Brit. J. Cancer, 74, 394-399 (1996).
15. MANGELSDORF, D.J. and EVANS, R.M., The RXR heterodimer and orphan receptors. Cell, 83, 841-850 (1995).
16. PETER, M. and HERSKOWITZ, I., Joining the complex: cyclin-dependent kinase inhibitory proteins and cell cycle. Cell, 79, 181-184 (1994).
17. PETERS, G., Stifled by inhibitors. Nature (Lond.), 371, 204-205 (1994).
18. ROSEWICH, S., STIER, U., BREMBECK, F., KAISER, A., PAPADIMITRIOU, C.A., BERDEL, W.E., WIEDENMANN, B. and RIECKEN, E.O., Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic cell lines. Gastroenterology, 109, 1646-1660 (1995).
19. SPORN, M.B. and ROBERTS. A., Role of retinoids in differentiation and carcinogenesis. Cancer Res., 43, 3034-3040 (1983).
20. STEINMAN, R.A., HOFFMAN, B., IRO, A., GUILLOUF, C., LIEBERMANN, D.A. and EL HOUSEINI, M.E., Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9, 3389-3396 (1994).
21. TEELMAN, K., TSUKAGUCHI, T., KLAUS, M. and ELIASON, J.F., Comparison of the therapeutic effects of a new arotinoid. RO 40-8757 and all-rtans- and 13-cis-retinoic acids on rat breast cancer. Cancer Res., 53, 2319-2325 (1993).
22. UCHIDA, T., INAGAKI, N., FURUICHI, Y. and ELIASON, J.F., Down regulation of mitochondrial gene expression by the anti-tumor arotinoid mofarotene (RO40-8757). Int. J. Cancer, 58, 891-897 (1994).
23. 3 in HL60 cells. Cancer Res., 56, 264-267 (1996).
24. ZUGMAIER, G., JAEGER, R., GRAGE, B., GOTTARDIS, M.M., HAVEMANN, K. and KNABBE, C., Growth-inhibitory effects of vitamin D analogous and retinoids on human pancreatic cancer cells. Brit. J. Cancer, 73, 1341-1346 (1996).